These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28052094)

  • 41. Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease.
    Chiba H; Kakuta Y; Kinouchi Y; Kawai Y; Watanabe K; Nagao M; Naito T; Onodera M; Moroi R; Kuroha M; Kanazawa Y; Kimura T; Shiga H; Endo K; Negoro K; Nagasaki M; Unno M; Shimosegawa T
    PLoS One; 2018; 13(3):e0194036. PubMed ID: 29547621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease.
    Shrestha UK; Karimi O; Crusius JB; Zhou F; Wang Z; Chen Z; van Bodegraven AA; Xiao J; Morré SA; Wang H; Li J; Xia B
    Inflamm Bowel Dis; 2010 Feb; 16(2):312-9. PubMed ID: 19714744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of GSTO1, GSTO2, GSTP1, GPX1 and SOD2 polymorphism with primary open angle glaucoma.
    Sobot V; Stamenkovic M; Simic T; Jerotic D; Djokic M; Jaksic V; Bozic M; Milic J; Savic-Radojevic A; Djukic T
    Exp Eye Res; 2022 Jan; 214():108863. PubMed ID: 34826418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
    Latiano A; Palmieri O; Corritore G; Valvano MR; Bossa F; Cucchiara S; Castro M; Riegler G; De Venuto D; D'Incà R; Andriulli A; Annese V
    Inflamm Bowel Dis; 2010 Jul; 16(7):1108-17. PubMed ID: 20024904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of multiple susceptibility loci for inflammatory bowel disease in an Italian cohort of patients.
    Latiano A; Palmieri O; Latiano T; Corritore G; Bossa F; Martino G; Biscaglia G; Scimeca D; Valvano MR; Pastore M; Marseglia A; D'Incà R; Andriulli A; Annese V
    PLoS One; 2011; 6(7):e22688. PubMed ID: 21818367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
    Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
    Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association between genetic polymorphism of glutathione peroxidase 1 (rs1050450) and keratoconus in a Turkish population.
    Ilhan A; Altun S; Durukan I; Yolcu U; Erdem U
    Arq Bras Oftalmol; 2019; 82(6):501-506. PubMed ID: 31576926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective association of tumor necrosis factor superfamily 15 (TNFSF15) polymorphic haplotype with Ulcerative Colitis and Crohn's disease in an Indian population.
    Baskaran K; Pugazhendhi S; Ramakrishna BS
    PLoS One; 2014; 9(12):e114665. PubMed ID: 25501099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial occurrence and inheritance studies in inflammatory bowel disease.
    Binder V; Orholm M
    Neth J Med; 1996 Feb; 48(2):53-6. PubMed ID: 8819799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease.
    Lin Z; Nelson L; Franke A; Poritz L; Li TY; Wu R; Wang Y; MacNeill C; Thomas NJ; Schreiber S; Koltun WA
    J Crohns Colitis; 2010 Jun; 4(2):132-8. PubMed ID: 21122496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease.
    Glas J; Seiderer J; Fischer D; Tengler B; Pfennig S; Wetzke M; Beigel F; Olszak T; Weidinger M; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Diegelmann J; Czamara D; Brand S
    Inflamm Bowel Dis; 2011 Sep; 17(9):1917-24. PubMed ID: 21830270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population.
    Ferguson LR; Browning BL; Huebner C; Petermann I; Shelling AN; Demmers P; McCulloch A; Gearry RB; Barclay ML; Philpott M
    Dig Liver Dis; 2008 Sep; 40(9):723-30. PubMed ID: 18394979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.
    Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Hoffmann HJ; Andersen Nexø B; Sode J; Vogel U; Andersen V
    PLoS One; 2015; 10(12):e0145302. PubMed ID: 26698117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of celiac disease genes with inflammatory bowel disease in Finnish and Swedish patients.
    Parmar AS; Lappalainen M; Paavola-Sakki P; Halme L; Färkkilä M; Turunen U; Kontula K; Aromaa A; Salomaa V; Peltonen L; Halfvarson J; Törkvist L; D'Amato M; Saavalainen P; Einarsdottir E
    Genes Immun; 2012 Sep; 13(6):474-80. PubMed ID: 22592522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.
    Krela-Kaźmierczak I; Michalak M; Wawrzyniak A; Szymczak A; Eder P; Łykowska-Szuber L; Kaczmarek-Ryś M; Drwęska-Matelska N; Skrzypczak-Zielińska M; Linke K; Słomski R
    Mol Biol Rep; 2017 Dec; 44(6):455-461. PubMed ID: 28993955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease.
    Tosa M; Negoro K; Kinouchi Y; Abe H; Nomura E; Takagi S; Aihara H; Oomori S; Sugimura M; Takahashi K; Hiwatashi N; Takahashi S; Shimosegawa T
    Scand J Gastroenterol; 2006 Jan; 41(1):48-53. PubMed ID: 16373276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease.
    Russell RK; Drummond HE; Nimmo ER; Anderson NH; Noble CL; Wilson DC; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Satsangi J
    Gut; 2006 Aug; 55(8):1114-23. PubMed ID: 16469794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.
    Takač B; Mihaljević S; Glavaš-Obrovac L; Kibel A; Suver-Stević M; Canecki-Varžić S; Samardžija M; Rajkovac I; Kovač D; Štefanić M
    Acta Clin Croat; 2020 Mar; 59(1):67-80. PubMed ID: 32724277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.
    Polgar N; Csongei V; Szabo M; Zambo V; Melegh BI; Sumegi K; Nagy G; Tulassay Z; Melegh B
    Int J Immunogenet; 2012 Jun; 39(3):247-52. PubMed ID: 22269120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DEFB1 gene 5' untranslated region (UTR) polymorphisms are marginally involved in inflammatory bowel disease in south Brazilians.
    Wilson TJ; Jobim M; Segat L; Bianco AM; Salim PH; Portela P; Jobim LF; Damin DC; Schwartsmann G; Roesler R; Crovella S
    Int J Immunogenet; 2014 Apr; 41(2):138-42. PubMed ID: 24034632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.